[Form 4] Carter Bankshares, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Carter Bankshares (CARE) director James W. Haskins reported an open-market sale of 2,000 common shares on 07/28/2025 at $17.84 each.

• Gross proceeds: ≈$35,680.
• Post-sale holdings: 61,900 shares held directly and 1,751 shares held indirectly through his spouse.
• No derivative securities were reported.

The filing signals a modest reduction in insider ownership but the director retains a sizeable stake, maintaining alignment with shareholders.

Positive

• Director retains 61,900 shares, indicating continued insider alignment after the sale.

Negative

• Insider sale of 2,000 shares at $17.84 may signal reduced short-term confidence.

Insights

Financial Analyst

TL;DR: Small insider sale; mildly negative sentiment, limited financial impact.

Haskins’ disposal represents a routine 3.1% trim of his directly held shares (2,000/63,900). While insider sales can hint at reduced confidence, the remaining 61.9k shares suggest continuing commitment. Transaction size is immaterial versus CARE’s ~18 million share float, so price pressure should be negligible. Investors may watch for additional sales to determine if this becomes a trend.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Haskins James W.

(Last) (First) (Middle)

1300 KINGS MOUNTAIN RD

(Street)

MARTINSVILLE VA 24112

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Carter Bankshares, Inc. [ CARE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								1,751	I	By spouse
Common Stock	07/28/2025		S		2,000	D	$17.84	61,900	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Abigail E. McGuire-Attorney-in-Fact	07/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CARE shares did Director James W. Haskins sell?

He sold 2,000 common shares on 07/28/2025.

At what price were the CARE shares sold?

The shares were sold at $17.84 per share.

How many CARE shares does Haskins now own?

He holds 61,900 shares directly and 1,751 shares indirectly via his spouse.

Were any derivative securities involved in the transaction?

No, no derivative securities were reported in this Form 4.

Is this Form 4 filing considered significant for investors?

The sale is small relative to total insider holdings, so the immediate impact is likely limited.